Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 12 | 2021 | 6497 | 0.780 |
Why?
|
| Viruses | 1 | 2018 | 350 | 0.530 |
Why?
|
| Fusobacterium nucleatum | 3 | 2021 | 165 | 0.510 |
Why?
|
| Feces | 6 | 2020 | 1365 | 0.490 |
Why?
|
| Stomach Neoplasms | 5 | 2020 | 1214 | 0.460 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2060 | 0.380 |
Why?
|
| Bacteria | 3 | 2021 | 2040 | 0.370 |
Why?
|
| Genes, Tumor Suppressor | 5 | 2020 | 1095 | 0.360 |
Why?
|
| Adenoma | 4 | 2021 | 2130 | 0.330 |
Why?
|
| Colon | 5 | 2021 | 1762 | 0.330 |
Why?
|
| Peptostreptococcus | 2 | 2017 | 29 | 0.320 |
Why?
|
| Metagenomics | 3 | 2019 | 399 | 0.310 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4044 | 0.290 |
Why?
|
| Immunotherapy | 1 | 2021 | 4057 | 0.290 |
Why?
|
| RNA, Ribosomal, 16S | 5 | 2020 | 900 | 0.280 |
Why?
|
| Hong Kong | 3 | 2018 | 156 | 0.260 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2021 | 3006 | 0.220 |
Why?
|
| Aspirin | 2 | 2021 | 3138 | 0.170 |
Why?
|
| Anticarcinogenic Agents | 1 | 2020 | 254 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2020 | 321 | 0.170 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 324 | 0.170 |
Why?
|
| Austria | 1 | 2018 | 180 | 0.170 |
Why?
|
| Transcription Factor AP-2 | 1 | 2018 | 83 | 0.170 |
Why?
|
| DNA, Bacterial | 3 | 2020 | 1528 | 0.170 |
Why?
|
| France | 1 | 2018 | 459 | 0.160 |
Why?
|
| Germany | 1 | 2018 | 791 | 0.150 |
Why?
|
| Occult Blood | 1 | 2016 | 174 | 0.150 |
Why?
|
| Zinc Fingers | 1 | 2018 | 599 | 0.140 |
Why?
|
| Case-Control Studies | 6 | 2019 | 21194 | 0.140 |
Why?
|
| Metagenome | 1 | 2018 | 388 | 0.130 |
Why?
|
| Azoxymethane | 3 | 2020 | 35 | 0.130 |
Why?
|
| Gastric Mucosa | 1 | 2017 | 611 | 0.130 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2017 | 342 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2019 | 894 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2020 | 6068 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1126 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2019 | 1235 | 0.120 |
Why?
|
| Biodiversity | 1 | 2015 | 341 | 0.120 |
Why?
|
| Oncogenes | 1 | 2018 | 1244 | 0.120 |
Why?
|
| Colonic Polyps | 1 | 2017 | 531 | 0.110 |
Why?
|
| beta Catenin | 1 | 2018 | 1053 | 0.110 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 507 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 1210 | 0.110 |
Why?
|
| Bacteremia | 1 | 2018 | 968 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 1600 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 2003 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2018 | 1335 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 8638 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 1959 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2244 | 0.090 |
Why?
|
| DNA Methylation | 2 | 2020 | 4099 | 0.090 |
Why?
|
| Germ-Free Life | 2 | 2020 | 193 | 0.090 |
Why?
|
| Bacteroides fragilis | 2 | 2020 | 214 | 0.090 |
Why?
|
| Indomethacin | 2 | 2019 | 350 | 0.080 |
Why?
|
| Epithelial Cells | 1 | 2020 | 3690 | 0.080 |
Why?
|
| Cholesterol | 1 | 2017 | 2866 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 3859 | 0.080 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 3812 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2018 | 3075 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14836 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 22989 | 0.070 |
Why?
|
| Male | 17 | 2021 | 349524 | 0.070 |
Why?
|
| Genome, Human | 1 | 2018 | 4493 | 0.070 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 2535 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 6684 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2018 | 10507 | 0.070 |
Why?
|
| Middle Aged | 11 | 2020 | 213752 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2018 | 5141 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 2165 | 0.060 |
Why?
|
| Mice | 9 | 2021 | 80876 | 0.060 |
Why?
|
| Humans | 21 | 2021 | 708843 | 0.060 |
Why?
|
| Animals | 13 | 2021 | 170486 | 0.060 |
Why?
|
| Area Under Curve | 2 | 2017 | 1688 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5982 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2019 | 8072 | 0.050 |
Why?
|
| Cell Proliferation | 4 | 2018 | 10803 | 0.050 |
Why?
|
| Aged | 9 | 2020 | 161488 | 0.050 |
Why?
|
| Bacillaceae | 1 | 2020 | 5 | 0.050 |
Why?
|
| Female | 12 | 2021 | 375205 | 0.050 |
Why?
|
| Macrophages | 1 | 2016 | 5784 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2020 | 76 | 0.050 |
Why?
|
| Dextran Sulfate | 1 | 2020 | 251 | 0.050 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2019 | 237 | 0.050 |
Why?
|
| Biological Availability | 1 | 2020 | 405 | 0.050 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2020 | 176 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 2018 | 2427 | 0.050 |
Why?
|
| Bifidobacterium | 1 | 2019 | 102 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2018 | 3693 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 39292 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 6338 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2019 | 4353 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2018 | 4310 | 0.040 |
Why?
|
| Dextrans | 1 | 2019 | 619 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 23020 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2018 | 23950 | 0.040 |
Why?
|
| Permeability | 1 | 2019 | 791 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 16959 | 0.040 |
Why?
|
| Acetophenones | 1 | 2017 | 52 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2017 | 50 | 0.040 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 3070 | 0.040 |
Why?
|
| HT29 Cells | 1 | 2017 | 207 | 0.040 |
Why?
|
| Apoptosis | 3 | 2018 | 10085 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2017 | 391 | 0.040 |
Why?
|
| Biosynthetic Pathways | 1 | 2017 | 141 | 0.040 |
Why?
|
| Cell Movement | 2 | 2019 | 5489 | 0.040 |
Why?
|
| Computational Biology | 2 | 2018 | 3568 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18375 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 962 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2017 | 629 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6766 | 0.030 |
Why?
|
| Methylation | 1 | 2018 | 1111 | 0.030 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2017 | 343 | 0.030 |
Why?
|
| Endocytosis | 1 | 2019 | 1018 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2018 | 1087 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 615 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2017 | 570 | 0.030 |
Why?
|
| Stomach | 1 | 2017 | 673 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2018 | 998 | 0.030 |
Why?
|
| Colitis | 1 | 2020 | 1140 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 1082 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 2264 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1060 | 0.030 |
Why?
|
| China | 1 | 2017 | 2251 | 0.030 |
Why?
|
| Drosophila | 1 | 2018 | 1467 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2017 | 742 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3714 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2018 | 1680 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 3093 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2020 | 6991 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 20172 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 6293 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2138 | 0.020 |
Why?
|
| RNA Interference | 1 | 2018 | 3026 | 0.020 |
Why?
|
| ROC Curve | 1 | 2016 | 3518 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3645 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 1482 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6765 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 1948 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4926 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2895 | 0.020 |
Why?
|
| Iron | 1 | 2016 | 1710 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9927 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 11239 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3464 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1999 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 3936 | 0.020 |
Why?
|
| Gene Expression | 1 | 2017 | 8014 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 7965 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 5300 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58184 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7622 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 20320 | 0.010 |
Why?
|
| Adult | 2 | 2018 | 211041 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 55940 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 71483 | 0.010 |
Why?
|
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_